Ilika achieves pivotal breakthrough in Goliath battery programme
Last updated: 02:14 19 Nov 2026 EST, First published: 23:49 03 Dec 2023 EST
Snapshot
- Ilika lines up 2027 battery deliveries as Goliath targets defence and marine
- Ilika has cracked problems that have beaten BYD, Toyota and Samsung. So why is nobody paying attention?
- Cavendish positive on Ilika after fundraise
- Ilika starts 2025 with big milestone for Stereax batteries as it targets commercial production
About the company
Ilika PLC is a pioneer in a ground-breaking solid-state battery technology designed to meet the specific demands of a wide range of applications in medtech, industrial IoT, electric vehicles and consumer electronics.
The company is headquartered in the UK.
How it is doing
Ilika PLC (AIM:IKA, OTCQX:ILIKF), the solid-state battery developer, expects further deliveries of its Stereax miniature batteries to customers in the first half of 2027.
Cirtec Medical, the US manufacturer that makes the batteries under licence, has built several hundred M300 units for product validation.
Stereax batteries are designed for medical implants and wireless sensors.
Cirtec also plans to put them into product demonstrators during 2027, which Ilika said will support validation by customers.
Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A) is targeting new commercial opportunities in defence and marine markets with the launch of ORKA, a dedicated brand for its deep-sea battery systems.
The UK solid-state battery developer said the new range is designed for autonomous underwater vehicles (AUVs), which are increasingly used for seabed surveys, monitoring critical infrastructure such as pipelines and fibre-optic cables, and military operations.
Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A), a pioneer of solid-state battery technology, has appointed a recently retired major general as a strategic adviser to help sell its batteries into the defence sector.
Robin Anderton-Brown joins after a 30-year military career that ended as two-star Director of Capability at UK Strategic Command.
Insight: Ilika has cracked problems that have beaten BYD, Toyota and Samsung. So why...
I'm going to jump down the rabbit hole of solid-state battery technology, potentially transformative for the electric vehicle industry, to reveal how a small UK company finds itself at its vanguard.
Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A), the business in question, also appears to have resolved many of the limiting issues that have thwarted the world's biggest carmakers and battery manufacturers. And yet this pioneer, listed on AIM, really doesn't appear to be receiving the recognition it deserves.
What the brokers say
Ilika PLC (AIM:IKA, OTCQX:ILIKF, FRA:I8A), the AIM-listed developer of solid-state battery technology, received a broker endorsement after raising £4.5 million through an accelerated bookbuild at 28p a share, alongside a retail offer of up to £500,000 at the same price.
Solid-state batteries replace the flammable liquid electrolyte in conventional lithium-ion cells with a solid material, promising faster charging, greater safety and longer life.
Cavendish analyst Ian McInally described the raise, which represents just under 10% of Ilika's market value, as broadly in line with the £5 million fundraising the broker had already assumed in its forecasts.
What management says
Ilika PLC (AIM:IKA, OTCQX:ILIKF) CEO Graeme Purdy joined Proactive's Stephen Gunnion with news of the successful commissioning of manufacturing equipment for Stereax batteries at Cirtec Medical’s facility in Lowell, Massachusetts, in the US. He explained that the company has completed commissioning and is moving into process qualification, with commercial sales anticipated later this year.
Purdy discussed the partnership with Cirtec, emphasising its role as a tier-one manufacturing company catering to leading medical device OEMs. This collaboration involves a ten-year licensing agreement, with Ilika retaining responsibility for manufacturing proprietary cathodes in the UK before final assembly in the US.
Purdy also highlighted the unique features of Stereax batteries, designed for active implantable medical devices. Their miniaturisation and high energy density are enabling innovative applications in medical technology, reducing surgical interventions and improving patient recovery.